CI Platform
Sign in
Libo Pharma Corp.7888Unknown exchange
Current ReportFundamental Reports

Asia / TAIWAN

Report Sections1

Available for this company

Reporting UnitBillions

Unknown exchange

To continue to view the full report

Buy this company's report, or subscribe to a plan.

Buy ReportSubscribe PlansAlready a member? Sign in

Company Overview

Libo Pharma Corp. is a clinical-stage biopharmaceutical company. It is engaged in developing in immunotherapeutic drugs. The company was founded on January 26, 2017 and is headquartered in Taipei, Taiwan.

Libo Pharma Corp. is a clinical-stage biopharmaceutical company. It is engaged in developing in immunotherapeutic drugs. The company was founded on January 26, 2017 and is headquartered in Taipei, Taiwan.

Includes quarterly earnings and dividends.

Company Details

Major IndustryPharmaceuticals & Biotechnology
Sub IndustryBiological Products Exc. Diagnostic
CountryTAIWAN
Employeesn/a
Reporting UnitBillions
Primary ExchangeUnknown exchange
Instrument TypeEquity
Wright IDC158K840F

Key Metrics

Current price$27.20
Market cap$2.05 B
P/E ration/a
Common shares75.2 M
Share typeGu
Quality ratingLBD0
Dividend yieldn/a

Recent stock performance

1 Week0.0%
4 Week-10.2%
13 Week-2.9%

Officers

n/a

Address

TAIWAN

Phonen/a

Quarterly Earnings & Dividends

Quarterly earnings and dividend history is not available for this company.

Try another report for annual statements, Wright Quality history or comparative analysis.